In pituitary tumors, particularly somatotropinomas, multiple studies have reported that a reduced E-Cadherin expression is linked to aggressive histological subtypes, correlating with an increased tumor size, invasiveness, and a reduced responsiveness to somatostatin analogs [59,60,61]. This evidence concerns the gene CDH1 and growth hormone-producing pituitary gland neoplasm.